Herpesviral vulvovaginitis
ICD-10 A60.04 is a billable code used to indicate a diagnosis of herpesviral vulvovaginitis.
Herpesviral vulvovaginitis is an inflammatory condition of the vulva and vagina caused by the herpes simplex virus (HSV). It is characterized by painful lesions, itching, and discomfort in the genital area. The condition can present with vesicular lesions that may rupture, leading to ulceration and secondary bacterial infections. Patients may also experience systemic symptoms such as fever, malaise, and lymphadenopathy. Diagnosis is typically made through clinical examination and can be confirmed with laboratory tests, including viral cultures or polymerase chain reaction (PCR) assays. The condition is often recurrent, with episodes triggered by stress, illness, or immunosuppression. Management includes antiviral medications, symptomatic relief, and education on transmission and prevention. Screening for herpesviral infections is crucial in sexually active individuals, especially those presenting with genital symptoms.
Detailed patient history, including sexual history and previous episodes, as well as physical examination findings.
Patients presenting with genital lesions, recurrent vulvovaginal discomfort, or systemic symptoms.
Ensure clear documentation of the diagnosis and any laboratory tests performed to confirm herpes infection.
Comprehensive documentation of the patient's medical history, including any immunocompromising conditions.
Patients with recurrent herpes infections or those with atypical presentations.
Consideration of co-infections and the need for broader STI screening.
Used when laboratory confirmation of herpes is performed.
Document the reason for testing and the results.
Ensure that the testing aligns with the clinical presentation.
Common symptoms include painful genital lesions, itching, burning sensation, and systemic symptoms like fever and malaise.
Diagnosis is typically made through clinical examination and can be confirmed with laboratory tests such as viral cultures or PCR assays.
Treatment usually involves antiviral medications, symptomatic relief, and education on transmission prevention.
